Baird cuts Bright Minds Biosciences target price to $107 from $126
DRUG•Baird cut its target price for Bright Minds Biosciences to $107 from $126.
Related News
Inspire Medical Systems: Piper Sandler raises target price to $70 from $60
INSP•
Coinbase Global: KBW cuts target price to $221 from $237
COIN•
Aehr Test Systems: Jefferies cuts target price to $140 from $175
AEHR•
Imperial Oil: TD Cowen raises target price to C$164 from C$158
IMO•
Intercontinental Exchange price objective raised to $245 from $243
ICE•